Reference sequence (1): bacce-PHAC Identities normalised by aligned length. Colored by: consensus/70% and property |
1 bacce-PHAC 100.0% -------------MTTFATEWEKQLELYPEEYRKAYR------RVKRASEILLRE--PEPQVGLTPKEVIWTKNKTKLYRY-IPKQ--E-KTQRVPILLIYALINKPYIMDLTPGNSLVE 2 bacce-q2ebc5 92.8% -------------MTTFVTEWEKQLELCPEEYRNAYR------RLKRASEVLLRE--PEPQVGLTPKEVIWTKNKAKLYRY-IPKQ--E-TTHSVPILLIYALINKPYIMDLTPGNSLVE 3 bacme-PHAC 70.7% ------------MAIPYVQEWEKLIKSMPSEYKSSAR------RFKRAYEIMTTE--AEPEVGLTPKEVIWKKNKAKLYRY-TPVK--D-NLHKTPILLVYALINKPYILDLTPGNSLVE 4 rubxd-q1atg5 45.3% ------------MAQPVNAG-----GAAANGLEELLD------KYRRGMSIIVEG--ARIDTGQTPKEVVWTKNKARLYRY-EPYR--E-KKYRTPILIVYALINRPYVLDLIPGNSFIE 5 9arch-b3t6z4 32.2% --------MSENKFNP----------KIIGDFLNFSR------NFTEAPMKASVP--HEVKLGSTQFDVAYKEDKMRLLHF-KPLT--S-KQVRTPLLISYAVVNRYHIFDIDPKKSWVK 6 9cren-Q8NKN4 28.9% MR-----KKMNNSLIN----------YLVNDYFTFVRDPDNISKLKEIRKKLSNI--ENIKTGSSEYEVIRETTLFRLLHY-KPLK--Q-QTFKYPLLIVYALINKSYILDLQNDKSWIR 7 9eury-c1vc42 39.1% -------------MNPYSAPLEFQ-AQTWEDAAEAIE------QMTGAPDQLERM--QSVEVGQTPSEVVYSENKLDLLHY-EPRT--D-EQLDVPILIVYALINRPYILDLQPNRSVVR 8 halme-b3frm5 38.9% -------------MTPVTFALDLQ-RRQWEQAAELVD------RTSAASDRAETV--SEVSVGKTPNEVVYKENKLRLLHY-ESKT--E-TQYDVPILIVYALINRPYILDLQPDRSVVQ 9 9gamm-q2bmp7 34.3% -------------MKA----FDLDPAKVAHELFEFNR------KLLKSYNTLAQL--KEVDVDSTPYEVIYTEDKLRLRFY-QAQG--D-KRCNTPLLICYALVNRPYMIDLESQRSMLQ 10 chlfr-PHAC 31.7% -------------MLPFL--LQIHLEEATHESAQLTH------KLVKGMENLSQLREEDIEVGATPREVVFQEDKVKLYRF-KSPVDQK-KTVKTPILMVYALVNRPFMVDLQEDRSLVA 11 synsp-PHAC 33.2% -------------MLPFL--MQMRLDDATEEYTELIK------KIVKGIENLSRLREEDIEIGVTPKEAVYREEKLTLYHF-QSTV--Q-KQLRTPVLIVYALVNRPFMVDLQEDRSLVA 12 synsp-PHBC 32.0% MFLLFFIVHWLKIMLPFF--AQVGLEENLHETLDFTE------KFLSGLENLQGLNEDDIQVGFTPKEAVYQEDKVILYRF-QPVV--E-NPLPIPVLIVYALVNRPYMVDLQEGRSLVA 13 chrvi-phbc 35.4% -------------MFP----IDIRPDKLTQEMLDYSR------KLGQGMENLLNA--EAIDTGVSPKQAVYSEDKLVLYRYDRPEG--APEAQPVPLLIVYALVNRPYMTDIQEDRSTIK 14 thivi-phbc 33.1% -------------MRP----IDIRPDKLAQEMLDYTS------KLGQGMENLLNA--DAIDTGVSPKEAVYSEDKLVLYRYDTPAG--V-TPQKTPLLIVYALVNRPYMTDIQEDRSTIK 15 ectva-PHAC 33.1% -------------MIP----IQIRPDQVMDELTTFQN------KLTQGLQNLADA--GDIPSGVTPKEAVYKEDKLTLYRFQAPAS--V-VQHPVPVLIVYALVNRPYMTDLQDDRSTVK 16 magsm-a0l6t8 31.7% -------------MFP----LQLTPQSIAQELADFNK------NLAEGYKNLAEL--GPIEVGTSDKEVVYREDKMVLYRF-TPQV--K-KPHAVPMLIVYALVNRPYMTDLQEDRSTIR 17 strm5-b4smq6 30.6% ------------MKGP----LGFNADDLMQETLAMQR------KLMEGLKLLPQV--EDVDYGVTAREEVWRDGKVVLYRF-VGEQ--A-PTRRTPLLIVYALVNRPYMVDLQADRSLVQ 18 xanax-PHBC 31.5% ------------MKGP----LGFSAEDLMQETLSMQR------KLREGLKLLPGV--DDVDYGVTEREEVWRDGKVVLYRF-IGEQ--A-PVAKTPLLIVYALVNRPYMVDLQADRSLVK 19 xanor-q5h0p6 31.8% ------------MKGP----LGFSAEDLMQETLSMQR------KLREGLKLLPGV--DDVDYGVTERQEIWRDGKVVLYRF-IGEQ--A-PVAKTPLLIVYALVNRPYMVDLQADRSLVK 20 xanca-PHBC 31.2% ------------MKGP----LGFSAEDLMQETLSMQR------KLREGLKLLPGV--EDVDYGVTERQEVWRDGKVVLYRF-VGDA--A-PVARTPLLIVYALVNRPYMVDLQADRSLVK consensus/100% .............h.s.............tt..t..p......ph.t....h..........s.o..p.hhppthh.Lhha..s..........hPhLh.YAllN+.ahhDl..tpShlt consensus/90% .............h.s.........t.h.p-hhph.c......phhpu.p.h.t...tt.phG.o.hp.lapcsKhhLh+a..s....t.....sPlLllYALlN+PahhDlp.spShlt consensus/80% .............hhP....htht.tphhp-hhph.c......+hhpu.c.L.th..tplphG.T.pEslapcsKhhLh+a..s.t..t...hpsPlLIVYALlNRPYhhDLp.s+Shlp consensus/70% .............hhP....hthp.cphhpEhhph.+......+ltcuhc.L.ph..p-lcsGhTs+Eslap-sKhhLYRa.tstt..t.p.hcsPlLIVYALlNRPYhhDLQssRShVc 1 bacce-PHAC 100.0% YLVDRGFDVYMLDWGTFGLEDSHLKFDDFVFDYIAKAVKKVMRTAKSDEISLLGYCMGGTLTSIYAALHPHMPIRNLIFMTSPFDFSET--GLYGPLL----DEKYFNLDKAVDTFGNIP 2 bacce-q2ebc5 92.8% YLVDRGFDVYMLDWGTFGLEDRHLKFDDFVFDYIAKAVKKVMRTAKSDEISLLGYCMGGTLTSIYAALHPHMPIRNLIFMTSPFDFSNT--GLYGPLL----DEKYFNLDKAVDTFGNIP 3 bacme-PHAC 70.7% YLLNRGFDVYLLDWGTPGLEDSNMKLDDYIVDYIPKAAKKVLRTSKSPDLSVLGYCMGGTMTSIFAALNEDLPIKNLIFMTSPFDFSDT--GLYGAFL----DDRYFNLDKAVDTFGNIP 4 rubxd-q1atg5 45.3% YLVGEGFDVYMLDWGIPGDEDAEMSFEHYVLDYLPRAARKVMRTSGTEDYTLFGYCMGGTMSAMYAALFPE-RMRNLVLLTAPIAFPKEHLGLYALFT----DSKYLDPGIMADAFGCIP 5 9arch-b3t6z4 32.2% NLLEQGFDVYLIDWGTPSKIDKFLGFDEYVNRYLDNCVDFICDETNVDKVSIQGYCTGGTLATVYSSLHPE-RVKNLIATAPVIDGWKDT-TVVSNI------AKYFDVDKLVDTVGNMP 6 9cren-Q8NKN4 28.9% NLLEQGINVYLIDWKPPSKLDKYITVDDYVNLFIYECVEYIKNIENIDQISLQGYCMGGTMSLMYTSLYQK-NIKNLVTIAPIVDAEKDK-SVIKNM------AEHMDIDKVLSYHENFP 7 9eury-c1vc42 39.1% TLLDQGLDVYLIDWGEPSRLDASLTLDDYVNRYIENCVDVVRDRSDQDSINVLGYCMGGTMSAMYTALHPE-KVRNLGLMASGLCFNDTG-GTLEFWG----DEEYYNPEAVTDVSGNVP 8 halme-b3frm5 38.9% TLLEQGFDVYLIDWGEPSRLDTHLTLDDYVTRYIDNCVDIVRDRSGQDSINLLGYCMGGTMSVMYAALFPE-KVRNLGLMAAGLVFDDTG-GVLERWG----DEQYYSPKAVTDAFGNVP 9 9gamm-q2bmp7 34.3% RLLEAGLDVYLIDWGYPDPADRYLDLDDYINEYVNNCVESVLAHAGVEKTNLLGICQGGTFSLCYTSLNPE-KIKNLITMVTPVDFQTED-NLLYHL------AKYVDADLAVETYGNIP 10 chlfr-PHAC 31.7% NLLKLGLDIYLIDWGYPGRGDRWLTLDDYINGYLNNCVDFIRTSHQLDKVNLLGICQGGTFSLCYSSLYPD-KVNNLVVMVAPVDFHQPE-TLLNMRGGCTLGAEAIDVDLMVDALGNIP 11 synsp-PHAC 33.2% NLLKLGLDIYLIDWGYPTRADRWLTLDDYINGYINNCVDFIRKKHDLDKINLLGICQGGTFSLCYSAIYPE-KVKNLIVMVTPVDFQISD-SLLYMRGGCTLGAEALDIDLMVDCLGNIP 12 synsp-PHBC 32.0% NLLKLGLDVYLIDWGYPSRGDRWLTLEDYLSGYLNNCVDIICQRSQQEKITLLGVCQGGTFSLCYASLFPD-KVKNLVVMVAPVDFEQPG-TLLNARGGCTLGAEAVDIDLMVDAMGNIP 13 chrvi-phbc 35.4% GLLATGQDVYLIDWGYPDQGDRALTLDDYINGYIDRCVDYLREAHGVDKVNLLGICQGGAFSLMYSALHPD-KVRNLVTMVTPVDFKTPD-NLLSAW------VQNVDIDLAVDTMGNIP 14 thivi-phbc 33.1% GLLATGQDVYLIDWGYPDQADSALTLDDYINGYIDSCVDYLCETHEVDQVNILGICQGGAFSLMYASLHPD-KVKNLVTMVTPVDFKTPG-NLLSAW------VQNVDIDLAVDTMGNIP 15 ectva-PHAC 33.1% GLLEAGMDVYLIDWGYPDRADRFLTMDDYLNGYLDRCVDEICRRHNLDKINILGICQGGTFSLCYSAMHPE-KVQNLITMVTPVDFQTPD-NILSHW------VKHVDIDTLVDTMGNVP 16 magsm-a0l6t8 31.7% GLLEEGMDVYLIDWGYPDAADRYLGLEDYVDGYIKRSVNHICRSHDLDAINLLGICQGGAFSLCFAALYPE-KVKNLVTMVTPVDFQTPD-NMLSLW------ARHLDVDLLVETMGNVP 17 strm5-b4smq6 30.6% KLLALGQDVYVLDWGYPDRSERFQTLEDYLLRYIDGAVDALRARSG-GPVDMLGICQGGVFALCYAALRRQ-KLGKLITMVTPVDFHTAD-NMLSHW------ARQVDVDLLVDTLGNIP 18 xanax-PHBC 31.5% GLLSHGQDVYVLDWGYPDRSERYLTLEDYLLRYIDGAVDHLRAQSGLQAVDVLGICQGGTFSLCYAALQRD-KVRNLITMVTPVDFHTPD-NMLSNW------ARMVDVDLFVDTMGNVP 19 xanor-q5h0p6 31.8% GLLSHGQDVYVLDWGYPDRSERYLTLEDYLLRYIDGAVDRLRAQSGLEAIDVLGICQGGTFSLCYAALQRE-KVRNLITMVTPVDFHTPD-NMLSNW------ARMVDVDLFVDTMGNVP 20 xanca-PHBC 31.2% GLLGHGQDVYVLDWGYPDRSERYLTLEDYLLRYIDGAVDHLRAASGLEAVDVLGICQGGTFALCYAALERA-KIRNLITMVTPVDFHTPD-NMLSNW------ARMVDVDLFVDTMGNVP consensus/100% .Llt.G.slYhlDWt..s..-t..th-cal..al.tssp.lht.tt...hsh.GhC.GGshs.hasuh..t..htpLhhhss.hsh.....shh..h.......p.hs.thhhph.tshP consensus/90% .Llt.G.DVYhlDWG.Ps..-p.hph-DYl.tYl.tsVchlhtttt.ptlslhGhC.GGshs.hYsuL..c..lpNLlhhssshsFpps..shht.h.......p.hs.-hhs-shGNlP consensus/80% tLLttG.DVYllDWGhPsttDphLsh-DYl.tYlspsVchlhtppt.-tlslLGhC.GGThohhYuuL..c.+l+NLlhMssPlDFppst.shlt.h......schhslDhhVDshGNlP consensus/70% sLLppGhDVYllDWGhPsptD+aLoL-DYl.tYIspsV-hlpppps.-plslLGhC.GGThSlhYuALaP-.Kl+NLlsMsoPlDFppss.slLs.h......schhDlDhhVDshGNlP 1 bacce-PHAC 100.0% PEMIDFGNKMLKPITNFVGPYVALVDRSENERFVESWRLVQKWVGDGIPFPGESYRQWIRDFYQNNKLVKGELVIRGQKVDLANIKANVLNISGKRDHIALPCQVEALLDHI-SSTDKQY 2 bacce-q2ebc5 92.8% PEMIDFGNKMLKPVTNFVGPYVALLDRSENEKFVTSWKLVQKWVGDGIPFPGEAYRQWIRDFYQKNKLVKGELVIRGQKVDLKNIKANVLNISARRDHIALPCQVEALLEHI-SSVDKQY 3 bacme-PHAC 70.7% PEMIDFGNKMLKPITNFYGPYVTLVDRSENQRFVESWKLMQKWVADGIPFAGEAYRQWIRDFYQQNKLINGELEVRGRKVDLKNIKANILNIAASRDHIAMPHQVAALMDAV-SSEDKEY 4 rubxd-q1atg5 45.3% GEIIDTGNRMLRPVTNYVGTYVSMWERIFEDKPMETWLAMNKWVNDGPPFPGAAFKQWITEFYQQNRLVKGEIRLRGRRVDLSNIRCPLLSVAGKKDHICTVPQAEAIMDLV-SSEDKEF 5 9arch-b3t6z4 32.2% PEFIYFCFSILKPFEQGVEKYIKFLNNIDNEKYVDNFLKIEKWLDETPPIPGELFRQWIKDIYQDNLLIQNKMYVGNKHVSLKNLNMPVFTQVAIGDHLVSPECSMPLHYAV-SSTDKTL 6 9cren-Q8NKN4 28.9% YELLYLVYASLKPFKQGVNKYYNLFKNFEDESFVQNFLRIEKWLYDTPPIAGETFRQWVKDIYQQNLFAKNKMIVGENKINLSNIKVPVLNVVAEFDHLVTSDSSSSLNNLI-SSQDKSL 7 9eury-c1vc42 39.1% SEFLDVGFALMDPVDNYLTKYIRLFENLDNDSFVENFARMEKWLSDGIDVAGETYNQFLQDIYQDNKLVNGELMLGEQHVDLANIDMPVIQIIGEHDHLIPPESSIPFNDAI-ASDDTMV 8 halme-b3frm5 38.9% SEFLDVGFALMDPVENFVTKYVRLFENVENESFVENFSRMEQWLSDGIDVAGETYKQFLEDVYQQNKLAQNELMLDGKQVDLERLEMPILQIVGEYDHLIPPEASKPFNDLV-PSEDTEV 9 9gamm-q2bmp7 34.3% GSMLNDSYNSLMPMRLGVQKNLGMPNQLENRESALSFLRMEKWIYDSPDQAGEAFREFITQFFQQNKLIHGEAMIGDKQVDLGKITQPVLNIFGSFDHLVPPKASTALADHV-NSADYQE 10 chlfr-PHAC 31.7% GDFLNLEFLMLKPQQLGIQEYLDVPDLMDSPEKLLNFLRMEKWIFDSPDQAGETYRQFMKDFYQGNKLIKNQVKIGDRQVNLLNLTMPILNLYAEKDHLVPPASSLALAKYI-DTQDYTA 11 synsp-PHAC 33.2% GDFLNFEFLMLKPRQLGIQKYLDFPEIMHSEDKLLNFLRMEKWIFDSPDQAGEAYRQFLKDFYQANKLIKGEVTIGDKQVNLGNIRMPVLNLYAEKDHLVPPRSSIALERYI-GTTDYTV 12 synsp-PHBC 32.0% GDYLNLEFLMLKPLQLGYQKYLDVPDIMGDEAKLLNFLRMEKWIFDSPDQAGETYRQFLKDFYQQNKLIKGEVMIGDRLVDLHNLTMPILNLYAEKDHLVAPASSLALGDYLPENCDYTV 13 chrvi-phbc 35.4% GELLNWTFLSLKPFSLTGQKYVNMVDLLDDPDKVKNFLRMEKWIFDSPDQAGETFRQFIKDFYQNNGFLNGGVVLGGQEVDLKDITCPVLNIFALQDHLVPPDASRALKGLT-SSPDYTE 14 thivi-phbc 33.1% GELLNWTFLSLKPFSLTGQKYVNMVDMLDDPDKVKNFLRMEKWIFDSPDQAGETFRQFTKDFYQKNGFINGGVKLGGKEIDLKNVDCPVLNIYALQDHLVPPDASKALNPWS-AARTYTE 15 ectva-PHAC 33.1% GELLNWTFLNLKPYQLMGQKYLDMVEVLQDKDKLDNFLRMEKWIFDSPDQVGETYRQFIKDFYQKNKLMNGGLQIGEYEVSLANVTMPVLNIFAEQDHLVPPDASKALAGKV-GTKDYTE 16 magsm-a0l6t8 31.7% GELLNFTFLSMKPFSLTGQKYLDLVEIMQDKTKLCNFMRMEKWIFDSPDQAGEAFRQFIKMFYQENGLVNGTAQIGGKEVKLENITMPILNIYATLDHLVPPAASKVLKGLV-GSTDYTE 17 strm5-b4smq6 30.6% AELMNASYLMLKPFRLNVQKYVGLLDILDDKAALEDFLRMEKWIFDSPDLAGEAFRDFIKQFYQGNGLMYGTVRIGEEAVDLSKVTLPVLNIYAEQDHLVPPDASRAMRGRL-GTEDYTE 18 xanax-PHBC 31.5% ADLMNASYLMLKPFRLNLQKYVGLLDILDDKQALEDFLRMEKWIFDSPDLAGEAFREFVTVFYQRNGLVTGQVSIAGQAVDLQALDMPVLNIYAEHDHLVPPDASRALGGLV-GSDDYSE 19 xanor-q5h0p6 31.8% ADLMNASYLMLKPFRLNLQKYVGLLDILDDKQALEDFLRMEKWIFDSPDLAGEAFREFVTLFYQRNGLVTGQVRIGGQAVDLQALDMPVLNIYAQHDHLVPPDASRALRGLV-GTEDYTE 20 xanca-PHBC 31.2% ADLMNASYLMLKPFRLNLQKYVGLLDILDDKQALEDFLRMEKWIFDSPDLAGEAFREFVTQFYQRNGLVTGDVRIGGQAVDLHAVDMPVLNIYAEHDHLVPPDASRALRGLV-GSEDYTE consensus/100% .phh......h.P.p..ht..hth.p...p.t.h.sa.hhppWl.-s.s.sGt.appahp.haQtNhhh.sth.ltt..lpL.tlp.slhp..u..DHlh.s.ts.sh..h...s.sh.. consensus/90% s-hhsht.h.hcPhp..ht.Ylth.c..ps.phl.sahhhpKWl.Du.s.sGEsa+palp.hYQtNthhpsth.lttptVsLttlphslLslhu..DHls.Ptts.sh.thl.sotDhp. consensus/80% s-hlshsah.LKPhp.hhpcYlshh-.hcscphlpsFh+MEKWlhDu.s.sGEsaRpalppFYQpNtLlpGplhlssptVsLtslphPlLNlhuptDHLlsPpsShuLtshl.uopDhp. consensus/70% u-hlshsahhLKPhp.hlpKYlshh-hh-scphlpsFLRMEKWlhDoPD.AGEsaRQFlc-FYQpNtLlpGplhlGsppVDLpslphPVLNIhAppDHLVsPcuSpALtshl.uopDhp. 1 bacce-PHAC 100.0% VCLPTGHMSIVYGGTAVKQTYPTIGDWLDERS--K 2 bacce-q2ebc5 92.8% VCLPTGHMSIVYGGTAVKQTYPTIGEWLEERS--Q 3 bacme-PHAC 70.7% KLLQTGHVSVVFGPKAVKETYPSIGDWLEKRS--K 4 rubxd-q1atg5 45.3% FVLDAGHVGLMTGRGAKKGLWPKVSGWLSERS--G 5 9arch-b3t6z4 32.2% KLYPTGHVGMIASSFSQKTVLPELGKWLKERS--- 6 9cren-Q8NKN4 28.9% MKFPTGHVGLIASNFSQKNVLPKIGKWIQTH---- 7 9eury-c1vc42 39.1% IEFPTGHIGLSVSSKSHAELWPQVCDWYVQRS--- 8 halme-b3frm5 38.9% IEGATGHIGLSVSSRSHGDLWPAVSDWFAER---- 9 9gamm-q2bmp7 34.3% MEVKAGHIGVFVSGKSQTQVAPAIVNWLAERD--- 10 chlfr-PHAC 31.7% KGFPVGHIGMYVSGKVQRDLPPVIADWLRNRD--- 11 synsp-PHAC 33.2% RSFPVGHIGIYVSSKVQRDLPPIIANWLNARE--- 12 synsp-PHBC 32.0% QSFPVGHIGMYVSGKVQRDLPPAIAHWLSERQ--- 13 chrvi-phbc 35.4% LAFPGGHIGIYVSGKAQKEVTPAIGKWLNER---- 14 thivi-phbc 33.1% LAFPGGHIGIYVSGKAQKEVTPAIGKWLNERS--- 15 ectva-PHAC 33.1% LSFPGGHIGIYVSGKAQKTVPPAIGKWVKERG--- 16 magsm-a0l6t8 31.7% LPFKGGHIGIYVSGRAQREVPPSIANWLKAR---- 17 strm5-b4smq6 30.6% SSFRGGHIGIYVSGRAQREVPATIDGWLKARD--A 18 xanax-PHBC 31.5% LSFRGGHIGIYVSGRAQREVPVAIHRWLQARGGNA 19 xanor-q5h0p6 31.8% LSFRGGHIGIYVSGRAQREVPVAIHRWLQERGGNA 20 xanca-PHBC 31.2% LSFRGGHIGIYVSGRAQREVPVAIHRWLQARGGNG consensus/100% ..h.sGHhuh.hu.hs.tth.s.l.tWh.t+.... consensus/90% h.h.sGHluhhhusts.pph.stltpWlttR.... consensus/80% hth.sGHlGlhsSupup+pl.PtIspWLptRt... consensus/70% hsa.sGHIGlhVSu+uQ+pl.PsIucWLppRs... |
MView 1.56, Copyright © 1997-2013 Nigel P. Brown